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Thiocyanates (SCN-) are ubiquitous in nature. There are
indispensable part of host defense system that act as a
substrate for lactoperoxidase (LPO). LPO oxidize air-
way surface liquid SCN- thereby generating antimicro-
bial agent hypothiocyanite (OSCN-) [1-3]. The OSCN-
formation is believed to be necessary for elimination of
bacteria  from airway mucosal surfaces [4]. Recently
publications report on impairment of this novel host
defense system in cystic fibrosis patients. In a study on
human and rat airway epithelia on cow tracheal explants
Moskwa et al. [4] showed that CF epithelia failed to
excrete SCN- and thus this system is 
In our study we present initial data on SCN- con-
centration in saliva of CF patients in comparison to
healthy non-smokers and healthy smokers. We decid-
ed to include the healthy smokers as an additional con-
trol group as it was previously shown that in this group
SCN- levels in saliva are elevated [5].
Materials and methods
Patients. The study was conducted in three groups of patients CF
patients, healthy non-smokers and healthy smokers. The groups
were sex and age matched. In CF patients delF508 was present in
13 (65%) allels. Other mutations were G542X - 2 allels (10%),
R553X - 2 allels (10%), 2134delT - 1 allel (5%), 3849+10kb C-T
- 1 allel (5%), one mutation was undefined.
Saliva samples. 5 ml of saliva was collected from each subject to
a sterile tube and the SCN- concentration was measured within 2 h
after collection. 
Thiocyanate designation. To 1 ml of whole saliva 0.03 ml of 2 M
HCl and 0.03 ml of 5% FeCl3 was added. Each sample was thor-
oughly mixed and estimated towards to control samples (1 ml H2O,
0.03 ml of 2 M HCl and 0.03 ml 5% FeCl3) at spectrophotometer
at wave length of  λ=570 nm.
Thiocyanate concentration was estimated according to calibration
plot prepared using standard solutions of NH4SCN. The data from
obtained from the calibration plot were calculated according to the
equation: 
Statistical analysis. The differences between mean were calculat-
ed using student t-test.
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strate for lactoperoxidase (LPO). In our study we present initial data on SCN- concentration in saliva of CF patients in compar-
ison to healthy non-smokers and healthy smokers. 5 ml of saliva was collected from each subject to a sterile tube and thiocyanate
concentration was measured in each sample. The results of the measurements are presented on Fig. 1. Mean concentration of
SCN- in saliva of CF patients was 0.031 ± 0.0052 g/l, in healthy non-smokers 0.039 ± 0.0048 g/l and in healthy smokers  0.048
± 0.0161 g/l. The differences between each group were statistically significant. Studies on larger group of patients and probably
on different material (BALF or induced sputum) should present interesting data complementing the in vitro studies.
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Results and discussion
The results of the measurements are presented on Fig.
1. Mean concentration of SCN- in saliva of CF patients
was 0.031 ± 0.0052 g/l, in healthy non-smokers 0.039
± 0.0048 g/l and in healthy smokers  0.048 ± 0.0161
g/l. The differences between groups were statistically
significant (Fig. 1) although the studied groups may be
considered to small. The saliva was chosen as study
material as it is one on the major sites of active LPO
and is fairly easy to obtain [6].
The impaired LPO function and differed thio-
cyanate concentration was described by Azen [7] and
this finding were confirmed in several recent studies
[8]. Childers at al. reviewed a problem of impaired
glutathione transport and its thiocyanate conjugates in
cystic fibrosis patients [9]. SCN- ions were used as
probe of Cl- channel pores since 1960s. It was shown
that CFTR channel is permeable to thiocyanates
[9,10]. In vivo studies are necessary to estimate exact
lack of thiocyanates in cystic fibrosis patients in sites
where LPO is active. Here we present preliminary
results of the study on SCN- concentration in a small
group of cystic fibrosis patients. Studies on larger
group of patients and probably on different material
(BALF or induced sputum) should present interesting
data complementing the in vitro studies.
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Fig. 1. The concentration of SCN- in saliva of CF patients, healthy
non-smokers and healthy smokers.
